Charles Schwab Investment Management »

Stoke Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Stoke Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Stoke Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Stoke Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.1M 205k 5.26
2023-09-30 $856k 217k 3.94
2023-06-30 $2.2M 207k 10.63
2023-03-31 $1.4M 164k 8.33
2022-12-31 $1.5M 165k 9.23
2022-09-30 $2.1M 162k 12.84
2022-06-30 $2.2M 166k 13.21
2022-03-31 $3.2M 151k 21.05
2021-12-31 $3.5M 148k 24.00
2021-09-30 $3.7M 146k 25.45
2021-06-30 $4.6M 137k 33.66
2021-03-31 $4.8M 122k 38.84
2020-12-31 $7.2M 116k 61.93
2020-09-30 $3.1M 94k 33.49
2020-06-30 $1.5M 64k 23.84
2020-03-31 $1.6M 70k 22.91
2019-12-31 $1.5M 53k 28.34
2019-09-30 $1.1M 52k 21.51